SEC 13F Intelligence

Peloton Wealth Strategists / VRTX

Peloton Wealth Strategists’s Vertex Pharmaceuticals Inc Position

Does Peloton Wealth Strategists own Vertex Pharmaceuticals Inc (VRTX)? Yes — 9.1K shares worth $4M (+1.65% of its 13F portfolio) as of Q1 2026, up from 9.0K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
9.1K
% of Portfolio
+1.65%
Quarters Held
8
currently held

Position History VRTX

Reported value by quarter
Q2 ’24: $270,000Q2 ’24Q3 ’24: $1MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $3MQ3 ’25Q4 ’25: $4MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.1K$4M+1.65%
Q4 20259.0K$4M+1.59%
Q3 20257.9K$3M+1.21%
Q2 20258.2K$4M+1.46%
Q1 20258.0K$4M+1.61%
Q4 20246.0K$2M+0.98%
Q3 20242.2K$1M+0.40%
Q2 2024575$270,000+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peloton Wealth Strategists’s full portfolio or all institutional holders of VRTX.